Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology

Posted on by

Sale of Indivumed’s Service Business to Crown Bioscience Enables Creation of Oncology R&D Powerhouse HAMBURG, Germany, April 4, 2023 /PRNewswire/ — After twenty years as one of the first personalized oncology companies, Indivumed today announced its evolution into Indivumed Therapeutics…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.